KMID : 0043320180410100967
|
|
Archives of Pharmacal Research 2018 Volume.41 No. 10 p.967 ~ p.976
|
|
Aspirin-inspired acetyl-donating HDACs inhibitors
|
|
Lim Ji-Ah
Song Yoo-Jin Jang Jung-Hee Jeong Chul-Ho Lee Soo-Yeun Park Byoung-Duck Seo Young-Ho
|
|
Abstract
|
|
|
Aspirin is one of the oldest drugs for the treatment of inflammation, fever, and pain. It is reported to covalently modify COX-2 enzyme by acetylating a serine amino acid residue. By virtue of aspirin¡¯s acetylating potential, we for the first time developed novel acetyl-donating HDAC inhibitors. In this study, we report the design, synthesis, in silico docking study, and biological evaluation of acetyl-donating HDAC inhibitors. The exposure of MDA-MB-231 cells with compound 4c significantly promotes the acetylation of ¥á-tubulin and histone H3, which are substrates of HDAC6 and HDAC1, respectively. In silico docking simulation also indicates that compound 4c tightly binds to the deep substrate-binding pocket of HDAC6 by coordinating the active zinc ion in a bidentate manner and forming hydrogen bond interactions with Ser531 and His573 amino acid residues. In particular, compound 4c (GI50?=?147 ¥ìM) affords the significant enhancement of anti-proliferative effect on MDA-MB-231 cells, compared with its parent compound 2c (GI50?>?1000 ¥ìM) and acetyl-donating group deficient compound 6 (GI50?=?554 ¥ìM). Overall, compound 4c presents a novel strategy for developing acetyl-donating HDAC inhibitors.
|
|
KEYWORD
|
|
Aspirin, Histone deacetylases, Cancers, Alzheimer¡¯s disease, Drug addiction
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|